Brian S. Posner, Director at Dyne Therapeutics, Inc. (DYN), bought 2,500 shares at $16.00 ($40K) on 2026-10-02, disclosed to the SEC on 2026-10-06.
Director Brian S. Posner purchased 2,500 shares for $40,000 at $16.00, marking the largest insider purchase in the company's history. This significant buy signals confidence in the stock's current valuation despite recent underperformance.
DYN is down 4.75% over the last 5 days and 36.33% over the last 30 days, trading 43.24% below its 52-week high of $27.22. The stock is currently 24.3% above its 52-week low of $12.43.
Insider purchased 2,500 shares at $16.00 on 2026-10-02, marking the largest insider purchase in the company's history.
The stock has a short interest of 16.01% of the float, indicating significant bearish sentiment among traders.
Something here stands out, but not much.